The serum anti-Spn IgG concentration was highest in the patients with non-recurrent AOM during the convalescent phase, suggesting that lower levels of production of anti-Spn IgG could increase the risks of recurrence and treatment failure [43]. Here, SPN is linked to infectious otitis media.